XML 41 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Supplemental Cash Flow Information Related to Operating and Financing Lease

The following table presents supplemental cash flow information related to operating and financing leases for the three months ended March 31, 2021 and 2020 (in thousands):

 

   

Three Months Ended

March 31,

 
    2021     2020  
Cash paid for amounts included in the measurement of financing lease liabilities:                
Operating cash flows from operating leases   $ 220     $ 78  
Operating cash flows from financing leases     10       3  
Financing cash flows from financing leases     41       17  
Right-of-use assets obtained in exchange for lease obligation:                
Operating lease, including lease acquired in Insight Genetics business combination     -       536  
Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases

The following table presents supplemental balance sheet information related to operating and financing leases as of March 31, 2021 (in thousands, except lease term and discount rate):

 

    March 31, 2021  
Operating leases        
Right-of-use assets, net   $ 2,801  
         
Right-of-use lease liabilities, current   $ 606  
Right-of-use lease liabilities, noncurrent     3,664  
Total operating lease liabilities   $ 4,270  
         
Financing leases        
Machinery and equipment   $ 537  
Accumulated depreciation     (226)  
Machinery and equipment, net   $ 311  
Current liabilities   $ 135  
Noncurrent liabilities     196  
Total financing lease liabilities   $ 331  
         
Weighted average remaining lease term        
Operating leases     6 years  
Financing leases     2.5 years  
         
Weighted average discount rate        
Operating leases        11.16%  
Financing leases     11.34%  
Schedule of Future Minimum Lease Commitments for Operating and Financing Leases

Future minimum lease commitments are as follows (in thousands):

 

   

Operating

Leases

   

Financing

Leases

 
Year Ending December 31,                
2021   $ 811     $ 134  
2022     1,096       124  
2023     1,000       124  
2024     889       -  
2025     869       -  
Thereafter     1,594       -  
Total minimum lease payments   $ 6,259     $ 382  
Less amounts representing interest     (1,760)       (51)  
Less: Tenant Improvement Allowance, net of administrative fee (1)     (229)       -  
Present value of net minimum lease payments   $ 4,270     $ 331  

 

(1) In accordance with ASC 842, a tenant allowance should be included in the measurement of the consideration in the lease agreement at inception and reflected as a reduction to the right-of-use asset and a corresponding reduction to the right-use-liability if the lessee both controls the construction of the tenant improvements and the expects to fully earn all of the tenant allowance. Oncocyte has met both conditions at the inception of the Irvine Lease and has recorded the Tenant Improvement Allowance accordingly. As the cash for the Tenant Improvement Allowance is received from the lessor under the terms of the Irvine Lease, the corresponding right-of-use liability will increase and will be amortized as part of the right-of use asset and liability amortization over the term of the Irvine Lease in accordance with ASC 842. As of March 31, 2021, the lessor had provided $1.1 million of the total $1.3 million Tenant Improvement Allowance, leaving a balance of $0.2 million.